FDA approves Imfinzi for early gastric and gastroesophageal cancers

The U.S. Food and Drug Administration has approved Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) for treating adult patients with resectable, early-stage, and…

Continue Reading

News Source: medicalxpress.com